Publicacións en colaboración con investigadores/as de Instituto de Investigación Sanitaria de Santiago de Compostela (36)

2024

  1. Clinical Effectiveness, Safety, and Compliance of Two Compounded Formulations of Tacrolimus Eye Drops: An Open-Label, Sequential Prospective Study

    International Journal of Molecular Sciences, Vol. 25, Núm. 18

  2. Development of inert coatings to prevent drug retention in 3D-printed diffusion cells

    International Journal of Pharmaceutics, Vol. 659

  3. Morquio A Syndrome: Identification of Differential Patterns of Molecular Pathway Interactions in Bone Lesions

    International Journal of Molecular Sciences, Vol. 25, Núm. 6

  4. Preclinical characterization of endotoxin-induced uveitis models using OCT, PET/CT and proteomics

    International Journal of Pharmaceutics, Vol. 662

  5. The Effect of Systemic Parameters and Baseline Characteristics in Short-Term Response Analysis with Intravitreal Ranibizumab in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration

    Pharmaceutics, Vol. 16, Núm. 1

  6. The Integration of Advanced Drug Delivery Systems into Conventional Adjuvant Therapies for Peri-Implantitis Treatment

    Pharmaceutics, Vol. 16, Núm. 6

2023

  1. Biomedical Applications of Lactoferrin on the Ocular Surface

    Pharmaceutics, Vol. 15, Núm. 3

  2. Bringing lipidic lyotropic liquid crystal technology into biomedicine

    Trends in Pharmacological Sciences

  3. Compression pressure-induced synergy in xanthan and locust bean gum hydrogels. Effect in drug delivery

    Journal of Drug Delivery Science and Technology, Vol. 89

  4. Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems, Part II: Long-Term Stability and Clinical Ocular Biopermanence

    Pharmaceutics, Vol. 15, Núm. 11

  5. Efficacy and Safety of Inhaled Ethanol in Early-Stage SARS-CoV-2 Infection in Older Adults: A Phase II Randomized Clinical Trial

    Pharmaceutics, Vol. 15, Núm. 2

  6. Estudio farmacocinético de adalimumab intravítreo en un modelo de rata con uveítis mediante PET

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  7. Intravitreal implants manufactured by supercritical foaming for treating retinal diseases

    Journal of Controlled Release, Vol. 362, pp. 342-355

  8. Lipidic lyotropic liquid crystals: Insights on biomedical applications

    Advances in Colloid and Interface Science, Vol. 313

2022

  1. Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence

    Pharmaceutics, Vol. 14, Núm. 10

  2. Fighting type 2 diabetes: Formulation strategies for peptide-based therapeutics

    Acta Pharmaceutica Sinica B, Vol. 12, Núm. 2, pp. 621-636

  3. PET study of intravitreal adalimumab pharmacokinetics in a uveitis rat model

    International Journal of Pharmaceutics, Vol. 627

  4. Stability of insulin eye drops in the treatment of refractory corneal ulcers

    Farmacia Hospitalaria, Vol. 46, Núm. 6, pp. 335-339

2021

  1. 3D printing of pharmaceutical products

    Additive Manufacturing (Elsevier), pp. 569-597

  2. Anti-inflammatory effect of tacrolimus/hydroxypropyl-β-cyclodextrin eye drops in an endotoxin-induced uveitis model

    Pharmaceutics, Vol. 13, Núm. 10